In recent years, a series of studies reported that Oct4 is highly expressed in various benign and malignant tumors, including glioma, lung cancer, bladder cancer, breast cancer, pancreatic cancer, hepatoma, and oral cancer [8, 16]. Here, POU5F1 is linked to glioma.